Absolute Nature – Full Spectrum 1000 mg CBG & CBD Oil Drops / Tincture – 30ml

Absolute Nature – Full Spectrum 1000 mg CBG & CBD Oil Drops / Tincture – 30ml – Ingredients

• Hemp Oil (Cannabis Sativa)
  Helps positively regulate mood patterns which help reduce anxiety and stress. It also promotes better sleep cycles and in some cases may offer a safe remedy for depression and bipolar disorders. Stimulates an anti-inflammatory response which helps reduce all forms of chronic aches and pains. Regular use also helps support joint health, mobility, and flexibility. Species: Cannabis Sativa,
  Family: Cannabinaceae,
  Domain: Plantae,
  The Best Supplements – Unique Ingredient Identifier: TBSI ID: IHDC0820,
  References:
  Hemp Products: BARON, Eric P. Comprehensive Review of Medicinal Marijuana, Cannabinoids, and Therapeutic Implications in Medicine and Headache: What a Long Strange Trip It’s Been … The Journal of Head and Face Pain, 2015, 55.6: 885-916. PMID:26015168,
  Brain / Mental Clarity: GULLUNI, Nadia; et al. Cannabis Essential Oil: A Preliminary Study for the Evaluation of the Brain Effects. Evidence-Based Complementary and Alternative Medicine, 2018, 2018: . PMID:29576792, PRETZSCH, Charlotte M.; et al. Effects of cannabidivarin (CBDV) on brain excitation and inhibition systems in adults with and without Autism Spectrum Disorder (ASD): a single dose trial during magnetic resonance spectroscopy. Translational psychiatry, 2019, 9.1: 1-10. PMID:31748505,
  Stress / Relaxation: MAULE, W. J. Medical uses of marijuana (Cannabis sativa): fact or fallacy? British journal of biomedical science, 2015, 72.2: 85-91. PMID:26126326.
  
  
  • Cannabinoid
    Cannabinoid: Cannabinoid, The Best Supplements – Unique Ingredient Identifier: TBSI ID: ISDBE110, References: Hemp Products: GROTENHERMEN, Franjo; MüLLER-VAHL, Kirsten The Therapeutic Potential of Cannabis and Cannabinoids. Deutsches Ärzteblatt International, 2012, 109.29-30: 495. PMID:23008748, MüCKE, Martin; et al. Cannabis-based medicines for chronic neuropathic pain in adults. Cochrane Database of Systematic Reviews, 2018, 3(3): CD012182. PMID:29513392, Brain / Mental Clarity: FERNáNDEZ-RUIZ, Javier; et al. The endogenous cannabinoid system and brain development. Trends in neurosciences, 2000, 23.1: 14-20. PMID:10631784, SCHONHOFEN, Patrícia; et al. Cannabinoid-Based Therapies and Brain Development: Potential Harmful Effect of Early Modulation of the Endocannabinoid System. CNS drugs, 2018, 32.8: 697-712. PMID:30109642.
    
    • CBD (C₂₁H₃₀O₂)
      Cannabidiol (CBD) is a constituent non-psychotomimetic of Cannabis Sativa with great psychiatric potential, including uses as an antidepressant-like and anxiolytic-like compound. It has anti-inflammatory and antipsychotic-like properties. CBD positive impact on the neural system helps reduce age-related cognitive decline. It also helps support focus, alertness & memory recall while reducing the frequency of migraines and headaches.
      CBD: Cannabidiol, Epidiolex,
      PubChem CID: 644019,
      Chemical Abstracts Service: CAS: 3556-78-3,
      ChemIDplus: 3556-78-3,
      WHO Anatomical Therapeutic Chemical Classification System: ATC code: N03AX24,
      FDA Substance Registration System – Unique Ingredient Identifier: UNII: 19GBJ60SN5,
      The Best Supplements – Unique Ingredient Identifier: TBSI ID: IS94C5F0,
      References:
      Hemp Products: FRAGUAS-SáNCHEZ, Ana Isabel; TORRES-SUáREZ, Ana Isabel Medical use of cannabinoids. Drugs, 2018, 78.16: 1665-1703. PMID:30374797, URITS, Ivan; et al. Use of cannabidiol (CBD) for the treatment of chronic pain. Best Practice & Research Clinical Anaesthesiology, 2020, 34(3): 463-477. PMID:33004159,
      Brain / Mental Clarity: DE MELLO SCHIER, Alexandre R.; et al. Antidepressant-like and Anxiolytic-Like Effects of Cannabidiol: A Chemical Compound of Cannabis Sativa. Current Drug Targets-CNS & Neurological Disorders, 2014, 13.6: 953-960. PMID:24923339, OSBORNE, Ashleigh L.; SOLOWIJ, Nadia; WESTON-GREEN, Katrina A Systematic Review of the Effect of Cannabidiol on Cognitive Function: Relevance to Schizophrenia. Neuroscience & Biobehavioral Reviews, 2017, 72: 310-324. PMID:27884751.
      
    • CBG (C₂₁H₃₂O₂)
      CBG: Cannabigerol,
      PubChem CID: 5315659,
      Chemical Abstracts Service: CAS: 25654-31-3,
      ChemIDplus: 25654-31-3,
      FDA Substance Registration System – Unique Ingredient Identifier: UNII: J1K406072N,
      The Best Supplements – Unique Ingredient Identifier: TBSI ID: IS953B20,
      References:
      Brain / Mental Clarity: CASCIO, Maria Grazia; et al. Evidence that the plant cannabinoid cannabigerol is a highly potent alpha2-adrenoceptor agonist and moderately potent 5HT1A receptor antagonist. British journal of pharmacology, 2010, 159.1: 129-141. PMID:20002104.
      
    • CBDA (C₂₂H₃₀O₄)
      CBDA: Cannabidiolic Acid,
      PubChem CID: 160570,
      Chemical Abstracts Service: CAS: 1244-58-2,
      ChemIDplus: 1244-58-2,
      FDA Substance Registration System – Unique Ingredient Identifier: UNII: FJX8O3OJCD,
      The Best Supplements – Unique Ingredient Identifier: TBSI ID: ISEA11E0,
      References:
      Brain / Mental Clarity: HEN-SHOVAL, D.; et al. Acute oral cannabidiolic acid methyl ester reduces depression-like behavior in two genetic animal models of depression. Behavioural brain research, 2018, 351: 1-3. PMID:29860002, ESPEJO-PORRAS, Francisco; et al. Motor effects of the non-psychotropic phytocannabinoid cannabidiol that are mediated by 5-HT1A receptors. Neuropharmacology, 2013, 75: 155-163. PMID:23924692.
      
    • CBDV (C₁₉H₂₆O₂)
      CBDV: Cannabidivarin, Cannabidivarol,
      PubChem CID: 11601669,
      Chemical Abstracts Service: CAS: 24274-48-4,
      ChemIDplus: 24274-48-4,
      FDA Substance Registration System – Unique Ingredient Identifier: UNII: I198VBV98I,
      The Best Supplements – Unique Ingredient Identifier: TBSI ID: IS94ED00,
      References:
      Brain / Mental Clarity: IANNOTTI, Fabio Arturo; et al. Nonpsychotropic plant cannabinoids, cannabidivarin (CBDV) and cannabidiol (CBD), activate and desensitize transient receptor potential vanilloid 1 (TRPV1) channels in vitro: potential for the treatment of neuronal hyperexcitability. ACS chemical neuroscience, 2014, 5.11: 1131-1141. PMID:25029033, PRETZSCH, Charlotte M.; et al. Effects of cannabidivarin (CBDV) on brain excitation and inhibition systems in adults with and without Autism Spectrum Disorder (ASD): a single dose trial during magnetic resonance spectroscopy. Translational psychiatry, 2019, 9.1: 1-10. PMID:31748505.
      
    • CBN (C₂₁H₂₆O₂)
      CBN: Cannabinol,
      PubChem CID: 2543,
      Chemical Abstracts Service: CAS: 521-35-7,
      ChemIDplus: 521-35-7,
      FDA Substance Registration System – Unique Ingredient Identifier: UNII: 7UYP6MC9GH,
      The Best Supplements – Unique Ingredient Identifier: TBSI ID: IS956230,
      References:
      Hemp Products: WONG, Hayes; CAIRNS, Brian E. Cannabidiol, cannabinol and their combinations act as peripheral analgesics in a rat model of myofascial pain. Archives of oral biology, 2019, 104: 33-39. PMID:31158702.
      
    • CBC (C₂₁H₃₀O₂)
      CBC: Cannabichromene, Pentylcannabichromene,
      PubChem CID: 30219,
      Chemical Abstracts Service: CAS: 20675-51-8,
      ChemIDplus: 20675-51-8,
      The Best Supplements – Unique Ingredient Identifier: TBSI ID: IS951410,
      References:
      Hemp Products: WONG, Hayes; CAIRNS, Brian E. Cannabidiol, cannabinol and their combinations act as peripheral analgesics in a rat model of myofascial pain. Archives of oral biology, 2019, 104: 33-39. PMID:31158702.
      
  • Terpenes ((C₅H₈)_n)
    Terpenes are as important as cannabinoids, they are the faithful sidekicks to cannabinoids. Without terpenes, cannabinoids would be far less effective.
    Terpenes: Terpenes, Terpene, The Best Supplements – Unique Ingredient Identifier: TBSI ID: ISEB9880.
    
  • Flavonoids
    Flavonoids: Flavonoids, Bioflavonoid, The Best Supplements – Unique Ingredient Identifier: TBSI ID: ISCBDB80.